These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30568715)

  • 1. A Comparative Study on Different Pharmaceutical Industries and Proposing a Model for the Context of Iran.
    Safari H; Arab M; Rashidian A; Kebriaee-Zadeh A; Abolghasem Gorji H
    Iran J Pharm Res; 2018; 17(4):1593-1603. PubMed ID: 30568715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Study of Comparative Advantage and Intra-Industry Trade in the Pharmaceutical Industry of Iran.
    Yusefzadeh H; Rezapour A; Lotfi F; Ebadifard Azar F; Nabilo B; Abolghasem Gorji H; Hadian M; Shahidisadeghi N; Karami A
    Glob J Health Sci; 2015 Apr; 7(6):295-307. PubMed ID: 26153184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the Factors Associated With Iran's Intra-Industry Trade in Pharmaceuticals.
    Yusefzadeh H; Hadian M; Abolghasem Gorji H; Ghaderi H
    Glob J Health Sci; 2015 Mar; 7(5):311-9. PubMed ID: 26156931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of Iran's
    Aghlmand S; Rahimi B; Farrokh-Eslamlou H; Nabilou B; Yusefzadeh H
    Iran J Pharm Res; 2018; 17(2):822-828. PubMed ID: 29881438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Study of Effective Factors on Iran's Pharmaceutical Export Supply and Demand.
    Najafi B; Mahboub-Ahari A; Nouraei Motlagh S; Otobideh SA; Rahimi B; Shabaninejad H; Yusefzadeh H
    Iran J Pharm Res; 2019; 18(4):2226-2232. PubMed ID: 32184887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conflicts of interest in research involving human beings.
    Greco D; Diniz NM
    J Int Bioethique; 2008; 19(1-2):143-54, 202-3. PubMed ID: 18664007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Policy Analysis Of Iranian Pharmaceutical Sector; A Qualitative Study.
    Ebadi Fardazar F; Sarabi Asiabar A; Safari H; Asgari M; Saber A; Ebadi Fard Azar AA
    Risk Manag Healthc Policy; 2019; 12():199-208. PubMed ID: 31807100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Structure of the World Pharmaceutical Market: Prioritizing Iran's Target Export Markets.
    Shabaninejad H; Yusefzadeh H; Mehralian G; Rahimi B
    Iran J Pharm Res; 2019; 18(1):546-555. PubMed ID: 31089388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addressing the impact of economic sanctions on Iranian drug shortages in the joint comprehensive plan of action: promoting access to medicines and health diplomacy.
    Setayesh S; Mackey TK
    Global Health; 2016 Jun; 12(1):31. PubMed ID: 27267898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing a national formulary based on a unified payment system in Iran.
    Ahmadi M; Amraei M; Samadbeik M
    Electron Physician; 2017 Jan; 9(1):3623-3629. PubMed ID: 28243416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient access to electronic health record: a comparative study on laws, policies and procedures in selected countries.
    Tavakoli N; Isfahani SS; Piri Z; Amini A
    Med Arch; 2013; 67(1):63-7. PubMed ID: 23678844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drivers of vulnerability to medicine smuggling and combat strategies: a qualitative study based on online news media analysis in Iran.
    Fakhrzad N; Yazdi-Feyzabadi V; Fakhrzad M
    BMC Health Serv Res; 2024 Mar; 24(1):383. PubMed ID: 38539159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Product Development in the Pharmaceutical Industry: Evidence from a generic market.
    Yousefi N; Mehralian G; Rasekh HR; Yousefi M
    Iran J Pharm Res; 2017; 16(2):834-846. PubMed ID: 28979339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data.
    Attaei MW; Khatib R; McKee M; Lear S; Dagenais G; Igumbor EU; AlHabib KF; Kaur M; Kruger L; Teo K; Lanas F; Yusoff K; Oguz A; Gupta R; Yusufali AM; Bahonar A; Kutty R; Rosengren A; Mohan V; Avezum A; Yusuf R; Szuba A; Rangarajan S; Chow C; Yusuf S;
    Lancet Public Health; 2017 Sep; 2(9):e411-e419. PubMed ID: 29253412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the Trade-Related Aspect of Intellectual Property Rights Agreement on Pharmaceutical Industry in Developing Countries: A Scoping Review.
    Fathi M; Peiravian F; Yousefi N
    Iran J Pharm Res; 2021; 20(4):339-351. PubMed ID: 35194451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Historical sketch of modern pharmaceutical science and technology (Part 4). Post World War II 50 years].
    Yamakawa K
    Yakushigaku Zasshi; 1995; 30(2):75-90. PubMed ID: 11613536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Influence of Emerging Markets on the Pharmaceutical Industry.
    Tannoury M; Attieh Z
    Curr Ther Res Clin Exp; 2017; 86():19-22. PubMed ID: 29234483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the vaccine industry in Iran in context of accession to WTO: a survey study.
    Hashemi Meshkini A; Kebriaeezadeh A; Dinarvand R; Nikfar S; Habibzadeh M; Vazirian I
    Daru; 2012 Aug; 20(1):19. PubMed ID: 23351841
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.